insights_auto
Istiqbol: 39.5% optimistik·18.6% pessimistik
Tahlilga kirishchevron_right
BMY:NYSE
Bristol Myers Squibb
59,12 US$
arrow_downward
-0,77%(-0,46) 1K
59,14 US$
arrow_upward
+0,03% (+0,016)bedtimeYopilgandan keyin
Savdolar yopilgan: 9-okt, 16:00:03 (GMT-4) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoBMY tikeri uchun statistika yaratilmoqda...
Ochish
58,88 US$
Yuqori
59,79 US$
Past
58,74 US$
Bozor kapitali
120,77 mlrd
Oʻrtacha hajm
11,23 mln
Hajmi
9,25 mln
Dividend
4,26%
Choraklik dividendlar
0,63 US$
Eks-dividend sanasi
2-okt, 2026
P/E koeffitsiyenti
13,02
52 haftalik eng yuqori
68,64 US$
52 haftalik eng past
42,52 US$
Aksiya boʻyicha daromad
4,54 US$
Beta
0,19
Muomaladagi aksiyalar
2,04 mlrd
Xodimlar soni
32 ming
Ochish
58,88 US$
Yuqori
59,79 US$
Past
58,74 US$
Bozor kapitali
120,77 mlrd
Oʻrtacha hajm
11,23 mln
Hajmi
9,25 mln
Dividend
4,26%
Choraklik dividendlar
0,63 US$
Eks-dividend sanasi
2-okt, 2026
P/E koeffitsiyenti
13,02
52 haftalik eng yuqori
68,64 US$
52 haftalik eng past
42,52 US$
Aksiya boʻyicha daromad
4,54 US$
Beta
0,19
Muomaladagi aksiyalar
2,04 mlrd
Xodimlar soni
32 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Simply Wall Street
·
3 soat oldin
What Bristol Myers Squibb Holders Saw Early
Foreign Policy Journal
·
23 soat oldin
Bristol Myers Squibb (NYSE: BMY) Or Novo Nordisk (NYSE: NVO): Which Healthcare Stock Offers The Better Investment Case In 2026?
The Globe and Mail
·
1 kun oldin
Bristol Myers Squibb vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026?
Profil
Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company headquartered in Princeton, New Jersey. The company's primary products are apixaban for people with atrial fibrillation; nivolumab, used to treat certain types of cancer; lenalidomide, used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes; abatacept, used to treat autoimmune diseases such as rheumatoid arthritis; pomalidomide, an anti-cancer medication used for the treatment of multiple myeloma and AIDS-related Kaposi sarcoma; ipilimumab, to treat cancer; and luspatercept for the treatment of anemia in beta thalassemia and myelodysplastic syndromes. In 2025, 69% of the company's revenues came from the United States.
The company is ranked 94th on the Fortune 500 and 173rd on the Forbes Global 2000. Wikipedia
Bristol Myers Squibb haqida
CEOChris Boerner
Xodimlar soni32,5 ming
Asos solingan1887
Bosh ofislarNyu-York shahri, Nyu-York, Amerika Qo‘shma Shtatlari
Sektor-
Veb-saytbms.com